Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1293228 Target Snapshot

Streptokinase A · SINGLE PROTEIN · Streptococcus pyogenes serotype M1

3,292Compounds
6Assays
34Approved Drugs
5,791.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P10520. Use UniProt P10520 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10520 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Streptokinase A as ChEMBL target CHEMBL1293228, mapped to UniProt P10520. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Streptokinase A
SINGLE PROTEIN · Streptococcus pyogenes serotype M1
As of 2026-09-13
ChEMBL target ID
CHEMBL1293228
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P10520
Streptokinase A
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Streptokinase A is the right protein anchor across sources, using UniProt P10520 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelStreptokinase A
UniProt AccessionP10520
Component TypeProtein
Sequence Length440 aa

Streptokinase A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Streptokinase A, mapped to UniProt P10520. Sequence length is 440 aa.

Mapped IDP10520
Review nameStreptokinase A
OrganismStreptococcus pyogenes serotype M1
Clinical Profile

Clinical Phase Distribution

34
Approved
2
Phase III
10
Phase II
Assay Mix

Activity Type Distribution

EC505,791.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2094567 7.2 EC50 63.0 Preclinical
CHEMBL278255 7.19 EC50 64.0 Clinical
CHEMBL2146063 7.19 EC50 65.0 Approved
CHEMBL1422078 7.16 EC50 69.0 Preclinical
CHEMBL1427178 7.13 EC50 74.0 Preclinical
CHEMBL1593888 7.13 EC50 74.0 Preclinical
CHEMBL1542263 7.11 EC50 78.0 Preclinical
CHEMBL12131 7.09 EC50 82.0 Clinical
CHEMBL1306986 7.09 EC50 81.0 Preclinical
CHEMBL1563791 7.05 EC50 90.0 Preclinical
Distribution

pChEMBL Value Distribution

1461
5.0
1020
5.5
263
6.0
102
6.5
20
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LINEZOLID
CHEMBL126
Approved 2000
MOXIFLOXACIN HYDROCHLORIDE
CHEMBL1200735
Approved 1999
GATIFLOXACIN
CHEMBL31
Approved 1999
MEROPENEM
CHEMBL127
Approved 1996
CEFPODOXIME PROXETIL
CHEMBL1201016
Approved 1992
MUPIROCIN
CHEMBL719
Approved 1987
METHACYCLINE HYDROCHLORIDE
CHEMBL2146123
Approved 1982
PIPERACILLIN SODIUM
CHEMBL1200820
Approved 1981
CEFACLOR ANHYDROUS
CHEMBL680
Approved 1979
CHLOROXINE
CHEMBL1200596
Approved 1976
FLOXURIDINE
CHEMBL917
Approved 1970
CHLORTETRACYCLINE HYDROCHLORIDE
CHEMBL2146063
Approved 1950
CHLORAMPHENICOL
CHEMBL130
Approved 1950
HEXACHLOROPHENE
CHEMBL496
Approved 1949
Assay Landscape

Assay Landscape

6
Total Assays
2,941
Tested Compounds
1
Assay Types
Functional — 6 assays, 2,941 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 2,941 5.3
organism-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine